Gyre Therapeutics, Inc. (GYRE): Weighted Average Diluted Shares
103.18M
Year ended 2025-12-31
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 103.18M | +0.9% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | 102.29M | n/c | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | 65.83M | -13.0% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | 75.69M | +147.0% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | 30.64M | n/a | 2023-03-30, From 2021-01-01 |
| No annual figure between 2012-12-31 and 2021-12-31. | |||
| 2012-12-31 | 33.48M | +5.8% | 2013-03-15, From 2012-01-01 |
| 2011-12-31 | 31.64M | +4.9% | 2013-03-15, From 2011-01-01 |
| 2010-12-31 | 30.15M | +17.6% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | 25.64M | n/a | 2012-03-06, From 2009-01-01 |